Breaking News Instant updates and real-time market news.

2021-01-15 08:43:08 KBR KBR $31.83 / +0.76 (+2.45%) 08:43 01/15/21 01/15 08:43 01/15/21 08:43	KBR price target raised to $40 from $34 at Truist Truist analyst Tobey Sommer raised the firm's price target on KBR to $40 from $34 and keeps a Buy rating on the shares as part of a broader research note on Business & Government Services, selecting the stock as one of his Best Ideas for 2021 in the space. The analyst expects the company to close most of its valuation discount this year by emphasizing attractive space exposure to investors, adopting a more active capital deployment strategy, and "effectively engraining the clean energy bent of the Tech Segment".	09 Feb
KBR KBR $31.83 / +0.76 (+2.45%) 12/18/20 UBS KBR price target raised to $35 from $28 at UBS 10/27/20 Citi KBR price target raised to $30 from $28 at Citi 06/15/20 Citi KBR price target raised to $29 from $25 at Citi 06/03/20 Goldman Sachs KBR upgraded to Buy from Neutral at Goldman Sachs

2021-01-15 08:43:08

KBR

$31.83 / +0.76 (+2.45%)

08:43

01/15/21

01/15

08:43

01/15/21

08:43

KBR price target raised to $40 from $34 at Truist

Truist analyst Tobey Sommer raised the firm's price target on KBR to $40 from $34 and keeps a Buy rating on the shares as part of a broader research note on Business & Government Services, selecting the stock as one of his Best Ideas for 2021 in the space. The analyst expects the company to close most of its valuation discount this year by emphasizing attractive space exposure to investors, adopting a more active capital deployment strategy, and "effectively engraining the clean energy bent of the Tech Segment".

09
Feb

KBR KBR

$31.83 / +0.76 (+2.45%)

12/18/20 UBS: KBR price target raised to $35 from $28 at UBS

10/27/20 Citi: KBR price target raised to $30 from $28 at Citi

06/15/20 Citi: KBR price target raised to $29 from $25 at Citi

06/03/20 Goldman Sachs: KBR upgraded to Buy from Neutral at Goldman Sachs

TODAY'S FREE FLY STORIES

Syndicate	Sun Communities offers to sell 7M of common stock » 07:53 03/04/21 03/04 07:53 03/04/21 07:53 SUI Sun Communities $149.91 / -1.31 (-0.87%) The offering consisting… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate SUI Sun Communities $149.91 / -1.31 (-0.87%) 11/06/20 Sun Communities says Jellystone Park Q3 sales up 21.8% 09/29/20 Safe Harbor Marinas enters merger agreement with Sun Communities for $2.11B 09/29/20 Sun Communities to acquire Safe Harbor Marinas for $2.1B SUI Sun Communities $149.91 / -1.31 (-0.87%) 12/15/20 Citi Sun Communities upgraded to Buy from Neutral at Citi 10/01/20 BMO Capital Sun Communities price target raised to $165 from $160 at BMO Capital 10/01/20 Berenberg Sun Communities initiated with a Buy at Berenberg 03/30/20 Evercore ISI Sun Communities upgraded to Outperform from In Line at Evercore ISI SUI Sun Communities $149.91 / -1.31 (-0.87%) 02/17/21 Sun Communities sees Q1 FFO $1.13-$1.17, one estimate $1.20 02/17/21 Sun Communities reports Q4 FFO $1.16, consensus $1.11 10/21/20 Sun Communities sees Q4 core FFO $1.00-$1.12, consensus $1.17 10/21/20 Sun Communities reports Q3 core FFO $1.60, consensus $1.43 01 Oct 29 Apr
Hot Stocks	Solid Biosciences names Erin Powers Brennan CLO, Joel Schneider COO » 07:53 03/04/21 03/04 07:53 03/04/21 07:53 SLDB Solid Biosciences $9.93 / -0.84 (-7.80%) Solid Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SLDB Solid Biosciences $9.93 / -0.84 (-7.80%) 12/11/20 Solid Biosciences announces $90M private placement 11/05/20 Solid Biosciences expects cash to fund operating expenses into 2H21 10/23/20 Ultragenyx, Solid Biosciences collaborate for DMD gene therapies 10/01/20 Solid Biosciences says FDA lifts clinical hold on IGNITE DMD trial SLDB Solid Biosciences $9.93 / -0.84 (-7.80%) 01/08/21 Chardan Solid Biosciences selloff on Sarepta news a buying opportunity, says Chardan 01/08/21 Credit Suisse Solid Biosciences upgraded to Neutral on Sarepta setback at Credit Suisse 01/08/21 Credit Suisse Solid Biosciences upgraded to Neutral from Underperform at Credit Suisse 10/23/20 Piper Sandler Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler SLDB Solid Biosciences $9.93 / -0.84 (-7.80%) 11/05/20 Solid Biosciences reports Q3 EPS (44c), consensus (34c) SLDB Solid Biosciences $9.93 / -0.84 (-7.80%) 12/11/20 Fly Intel: Wall Street's top stories at midday 12/11/20 Fly Intel: Pre-market Movers 03/15/21 Solid Biosciences - SLDB
Recommendations	Correction: Dynex, not Seagate, Spot Secondary priced at $18.35 07:51 03/04/21 03/04 07:51 03/04/21 07:51 STX Seagate $75.93 / +3.49 (+4.82%) , DX Dynex Capital $19.17 / -0.02 (-0.10%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options STX STX Seagate $75.93 / +3.49 (+4.82%) 02/24/21 Seagate says on track to deliver 50TB devices by 2026 02/24/21 Seagate says Lyve could open up $50B in market opportunity by 2025 02/24/21 Seagate sees mass capacity HDDs storing over 65% of exabytes in 2026 01/21/21 Seagate says 2020 'a very challenging year' STX DX STX Seagate $75.93 / +3.49 (+4.82%) 02/26/21 Mizuho Seagate price target raised to $78 from $65 at Mizuho 02/25/21 Craig-Hallum Seagate price target raised to $95 from $90 at Craig-Hallum 02/25/21 Benchmark Seagate price target raised to $82 from $70 at Benchmark 02/25/21 Loop Capital Seagate price target raised to $90 from $70 at Loop Capital DX Dynex Capital $19.17 / -0.02 (-0.10%) 12/18/20 Keefe Bruyette Dynex Capital downgraded to Market Perform from Outperform at Keefe Bruyette 11/23/20 BTIG Dynex Capital initiated with a Buy at BTIG 07/29/20 Ladenburg Dynex Capital upgraded to Buy from Neutral at Ladenburg STX DX STX Seagate $75.93 / +3.49 (+4.82%) 01/21/21 Seagate sees Q3 adjusted EPS $1.30, plus/minus 15c, consensus $1.26 01/21/21 Seagate reports Q2 adjusted EPS $1.29, consensus $1.13 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c DX Dynex Capital $19.17 / -0.02 (-0.10%) 02/04/21 Dynex Capital reports Q4 EPS $1.60, consensus 51c 10/28/20 Dynex Capital reports Q3 core EPS 61c, consensus 47c 04 Mar 04 Mar 29 Jan STX STX Seagate $75.93 / +3.49 (+4.82%) 02/22/21 Before the Move: Watch Seagate ahead of analyst day 02/18/21 Wells Fargo, Seagate upgrades among today's top calls on Wall Street 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference STX DX STX Seagate $75.93 / +3.49 (+4.82%) 02/18/21 Early notable gainers among liquid option names on February 18th 01/21/21 Seagate options imply 7.9% move in share price post-earnings 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish DX Dynex Capital $19.17 / -0.02 (-0.10%) 09/24/20 Largest borrow rate increases among liquid names 09/23/20 Largest borrow rate increases among liquid names
Hot Stocks	Kforce appoints Derrick Brooks to board of directors » 07:51 03/04/21 03/04 07:51 03/04/21 07:51 KFRC Kforce $53.46 / +1.3 (+2.49%) Kforce announced certain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly KFRC Kforce $53.46 / +1.3 (+2.49%) 01/20/21 Truist Kforce price target raised to $48 from $37 at Truist 01/04/21 Sidoti Kforce upgraded to Buy from Neutral at Sidoti 08/11/20 Truist Kforce price target raised to $35 from $30 at Truist 08/11/20 William Blair Kforce upgraded to Outperform from Market Perform at William Blair KFRC Kforce $53.46 / +1.3 (+2.49%) 02/08/21 Kforce sees FY21 EPS $2.68-$3.00, consensus $2.50 02/08/21 Kforce sees Q1 EPS 57c-65c, consensus 51c 02/08/21 Kforce reports Q4 EPS 86c, consensus 77c 01/19/21 Kforce expects Q4 EPS to exceed 78c per share, consensus 75c KFRC Kforce $53.46 / +1.3 (+2.49%) 02/08/21 Fly Intel: After-Hours Movers 09/21/20 Fly Intel: After-Hours Movers
Hot Stocks	LPL Financial announces proposed leverage-neutral transaction » 07:50 03/04/21 03/04 07:50 03/04/21 07:50 LPLA LPL Financial $134.56 / -0.2 (-0.15%) LPL Financial Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LPLA LPL Financial $134.56 / -0.2 (-0.15%) 02/17/21 LPL Financial announces launch of modernized brand identity 12/14/20 LPL Financial announces Brent Simonich as EVP, chief accounting officer 12/02/20 Macquarie to acquire Waddell & Reed for $25 per share 10/27/20 LPL Financial acquires Blaze Portfolio for approximately $12M LPLA LPL Financial $134.56 / -0.2 (-0.15%) 02/08/21 Citi LPL Financial price target raised to $203 from $171.50 at Citi 01/12/21 Barclays LPL Financial price target raised to $130 from $110 at Barclays 01/04/21 Wells Fargo LPL Financial price target raised to $122 from $110 at Wells Fargo 12/18/20 Compass Point LPL Financial price target raised to $112 from $85 at Compass Point LPLA LPL Financial $134.56 / -0.2 (-0.15%) 02/04/21 LPL Financial reports Q4 EPS $1.38, consensus $1.34 10/29/20 LPL Financial reports Q3 EPS $1.29, consensus $1.23 00:00 Today LPL Financial

Recommendations	Snowflake price target raised to $270 from $265 at Morgan Stanley » 07:48 03/04/21 03/04 07:48 03/04/21 07:48 SNOW Snowflake $246.86 / -23.73 (-8.77%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SNOW Snowflake $246.86 / -23.73 (-8.77%) 03/03/21 Snowflake CEO sees improving operating efficiency 03/03/21 Snowflake reports Q4 net revenue retention rate of 168% vs. 162% in Q3 03/03/21 Snowflake falls about 4% to $237 after Q4 earnings miss 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal SNOW Snowflake $246.86 / -23.73 (-8.77%) 07:05 Today Barclays Snowflake price target lowered to $270 from $295 at Barclays 06:31 Today Citi Snowflake price target lowered to $295 from $325 at Citi 06:10 Today Deutsche Bank Snowflake upgraded to Buy with $300 price target at Deutsche Bank 06:03 Today Deutsche Bank Snowflake upgraded to Buy from Hold at Deutsche Bank SNOW Snowflake $246.86 / -23.73 (-8.77%) 03/03/21 Snowflake sees FY22 product revenue $1.00B-$1.02B, consensus $1.10B 03/03/21 Snowflake sees Q1 product revenue revenue $195M-$200M, consensus $213.06M. 03/03/21 Snowflake reports Q4 EPS (70c), consensus (17c) 03/03/21 Notable companies reporting after market close 16 Sep SNOW Snowflake $246.86 / -23.73 (-8.77%) 09/26/20 Western Digital could have plenty of upside, Barron's says 09/15/20 Snowflake IPO priced at $120 per share, CNBC reports SNOW Snowflake $246.86 / -23.73 (-8.77%) 03/03/21 Fly Intel: After-Hours Movers 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry 01/03/21 Opening Day: Six IPOs to watch in 2021 12/15/20 Before the Move: Watch Snowflake into lockup expiration 03/11/21 Snowflake - SNOW SNOW Snowflake $246.86 / -23.73 (-8.77%) 03/03/21 Snowflake options imply 14.4% move in share price post-earnings 02/09/21 Snowflake call volume above normal and directionally bullish 02/03/21 Unusually active option classes on open February 3rd 01/07/21 Snowflake call volume above normal and directionally bullish
Hot Stocks	Aurora Mobile partners with Segway-Ninebot to promote smart mobility services » 07:48 03/04/21 03/04 07:48 03/04/21 07:48 JG Aurora Mobile $5.68 / -0.31 (-5.18%) Aurora Mobile announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly Options JG Aurora Mobile $5.68 / -0.31 (-5.18%) 02/26/21 Aurora Mobile, Farfetch enter partnership agreement 02/08/21 Aurora Mobile enters partnership agreement with iQIYI 01/12/21 Aurora Mobile partners with Dada Now on user experience, account security 01/05/21 Aurora Mobile enters user-centric partnership agreement with UP Fintech JG Aurora Mobile $5.68 / -0.31 (-5.18%) 12/24/20 Fly Intel: Pre-market Movers JG Aurora Mobile $5.68 / -0.31 (-5.18%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Periodicals	Walmart's Flipkart eyes U.S. listing via SPAC merger, Bloomberg reports » 07:47 03/04/21 03/04 07:47 03/04/21 07:47 WMT Walmart $127.55 / -2.54 (-1.95%) Walmart's Flipkart… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WMT Walmart $127.55 / -2.54 (-1.95%) 03/03/21 Walmart announces $350B commitment to U.S. manufacturing 03/01/21 Walmart drops $35 minimum for express delivery 02/24/21 BigCommerce announces Walmart Marketplace partnership for merchants 02/18/21 Walmart sees Q1 EPS flat to slightly up vs. last year, consensus $1.30 WMT Walmart $127.55 / -2.54 (-1.95%) 02/23/21 Evercore ISI Walmart accelerating change with investments, says Evercore ISI 02/19/21 Morgan Stanley Walmart terminal value rising with investments, says Morgan Stanley 02/19/21 Cowen Walmart weakness a buying opportunity, says Cowen 02/19/21 Deutsche Bank Walmart price target lowered to $166 from $170 at Deutsche Bank WMT Walmart $127.55 / -2.54 (-1.95%) 02/18/21 Walmart reports Q4 adjusted EPS $1.39, consensus $1.51 02/17/21 Notable companies reporting before tomorrow's open 02/17/21 Notable companies reporting before tomorrow's open 11/17/20 Walmart reports Q3 adjusted EPS $1.34, consensus $1.18 WMT Walmart $127.55 / -2.54 (-1.95%) 03/01/21 Goldman's Omer Ismail leaving to run Walmart's fintech startup, WSJ reports 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 02/18/21 Walmart to raise wages for 425,000 store associates, Yahoo Finance reports 02/14/21 Walmart COVID vaccine rollout heading to small towns, WSJ reports WMT Walmart $127.55 / -2.54 (-1.95%) 03/03/21 #SocialStocks: Facebook resumes political ads, Twitter announces long-term goals 03/01/21 Fly Insider: Cannae Holdings, Palantir among week's notable inside trades 03/01/21 Fly Intel: What to watch in Target's earnings report 02/18/21 Fly Intel: Wall Street's top stories for Thursday WMT Walmart $127.55 / -2.54 (-1.95%) 03/01/21 Unusually active option classes on open March 1st 02/18/21 Unusually active option classes on open February 18th 11/17/20 Unusually active option classes on open November 17th
General news	Treasury Market Outlook: stocks are broadly lower » 07:45 03/04/21 03/04 07:45 03/04/21 07:45 Treasury Market Outlook:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Dick's Sporting price target raised to $75 from $64 at UBS » 07:45 03/04/21 03/04 07:45 03/04/21 07:45 DKS Dick's Sporting $72.40 / -0.62 (-0.85%) UBS analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DKS Dick's Sporting $72.40 / -0.62 (-0.85%) 02/10/21 Dick's Sporting opening five stores in five states in February 02/01/21 Dick's Sporting Executive Chairman: I love this place, I will still be involved 12/18/20 Instacart announces partnership with Dick's Sporting Goods for same-day delivery 11/24/20 Dick's Sporting President says stores drove 90% of total Q3 sales growth DKS Dick's Sporting $72.40 / -0.62 (-0.85%) 02/16/21 Cowen Dick's Sporting price target raised to $87 from $81 at Cowen 02/05/21 Gordon Haskett Dick's Sporting initiated with a Hold at Gordon Haskett 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Citi Dick's Sporting upgraded to Buy from Neutral at Citi DKS Dick's Sporting $72.40 / -0.62 (-0.85%) 11/24/20 Dick's Sporting not providing an updated FY20 outlook at this time 11/24/20 Dick's Sporting reports Q3 adjusted EPS $2.01, consensus $1.01 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open DKS Dick's Sporting $72.40 / -0.62 (-0.85%) 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 12/10/20 Goldman Sachs says buy Floor & Decor, sell Best Buy 11/24/20 Fly Intel: Pre-market Movers 03/09/21 Dick's Sporting - DKS DKS Dick's Sporting $72.40 / -0.62 (-0.85%) 10/15/20 Dicks call volume above normal and directionally bullish 10/15/20 Unusually active option classes on open October 15th 10/14/20 Dicks call volume above normal and directionally bullish

Hot Stocks	Tonix Pharmaceuticals regains compliance with Nasdaq minimum price rule » 07:44 03/04/21 03/04 07:44 03/04/21 07:44 TNXP Tonix Pharmaceuticals $1.12 / -0.09 (-7.44%) Tonix Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events TNXP Tonix Pharmaceuticals $1.12 / -0.09 (-7.44%) 02/11/21 Tonix licenses technology for treatment of Prader-Willi syndrome 02/08/21 Tonix Pharmaceuticals receives FDA clearance to develop COVID-19 skin test 01/14/21 Tonix announces publication of patent application for TNX-1500 01/05/21 Tonix Pharmaceuticals, MGH enter collaboration on TNX-1500 TNXP Tonix Pharmaceuticals $1.12 / -0.09 (-7.44%) 02/25/21 Alliance Global Partners Tonix price target raised to $4 from $3 at Alliance Global Partners 12/21/20 H.C. Wainwright H.C. Wainwright reiterates Buy on Aptinyx after competitor fails in PTSD 08/20/20 Alliance Global Partners Tonix price target raised to $3 from $2.50 at Alliance Global Partners TNXP Tonix Pharmaceuticals $1.12 / -0.09 (-7.44%) 12/24/20 Fly Intel: Pre-market Movers 03/26/21 Tonix Pharmaceuticals Holding Corp.
Hot Stocks	Genetic Technologies signs multi-year distribution agreement for COVID Risk Test » 07:44 03/04/21 03/04 07:44 03/04/21 07:44 GENE Genetic Technologies $4.50 / +0.09 (+2.04%) Genetic Technologies is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Options GENE Genetic Technologies $4.50 / +0.09 (+2.04%) 03/01/21 Genetic Technologies trading halted, news pending 01/21/21 Genetic Technologies provides update on COVID-19 disease severity risk test 12/02/20 Genetic Technologies secures U.S., Australia distribution rights for Predictix 10/01/20 Genetic Technologies outlines findings in relation to COVID-19 Risk Test GENE Genetic Technologies $4.50 / +0.09 (+2.04%) 01/05/21 Largest borrow rate increases among liquid names 12/23/20 Largest borrow rate increases among liquid names
Hot Stocks	Wipro to acquire Capco » 07:42 03/04/21 03/04 07:42 03/04/21 07:42 WIT Wipro $6.47 / +0.005 (+0.08%) Wipro announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings WIT Wipro $6.47 / +0.005 (+0.08%) 02/15/21 Wipro announces five-year strategic partnership with Telefonica Germany 01/15/21 Wipro chosen by Fiat Chrysler to establish first global digital hub in India 01/13/21 Wipro sees Q4 IT Services revenue up 1.5%-3.5% sequentially to $2.1B-$2.14B 12/10/20 Wipro, LogiNext announce integrated logistics platform partnership WIT Wipro $6.47 / +0.005 (+0.08%) 12/21/20 Goldman Sachs Wipro resumed with a Sell at Goldman Sachs 10/14/20 Investec Wipro downgraded to Hold from Buy at Investec 10/06/20 ICICI Securities Wipro downgraded to Hold from Buy at ICICI Securities 07/16/20 Wedbush Infosys upgraded to Outperform on improving visibility at Wedbush WIT Wipro $6.47 / +0.005 (+0.08%) 01/13/21 Wipro reports Q3 EPS 7c, two estimates 6c 10/13/20 Wipro sees Q3 IT Services revenue up 1.5%-3.5% sequentially to $2.02B-$2.06B 10/13/20 Wipro reports Q2 EPS 6c, two estimates 6c
Syndicate	nLight 2.206M share Spot Secondary priced at $34.00 » 07:42 03/04/21 03/04 07:42 03/04/21 07:42 LASR nLight $36.79 / -0.93 (-2.47%) The deal range was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly LASR nLight $36.79 / -0.93 (-2.47%) 02/18/21 DA Davidson nLight price target raised to $48 from $30 at DA Davidson 02/18/21 Craig-Hallum nLight price target raised to $48 from $32 at Craig-Hallum 02/18/21 Canaccord nLight price target raised to $53 from $27 at Canaccord 01/21/21 Berenberg nLight assumed with a Hold at Berenberg LASR nLight $36.79 / -0.93 (-2.47%) 02/17/21 nLight sees Q1 revenue $56M-$62M, consensus $56.13M 02/17/21 nLight reports Q4 adjusted EPS 12c, consensus 6c 11/05/20 nLight sees Q4 revenue $59M-$65M, consensus $56.8M 11/05/20 nLight reports Q3 EPS 12c, consensus 1c 04 Mar LASR nLight $36.79 / -0.93 (-2.47%) 03/03/21 Fly Intel: After-Hours Movers 11/05/20 Fly Intel: After-Hours Movers
Downgrade	WSFS Financial downgraded to Neutral from Outperform at Boenning & Scattergood » 07:41 03/04/21 03/04 07:41 03/04/21 07:41 WSFS WSFS Financial $51.90 / +0.68 (+1.33%) Boenning &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly WSFS WSFS Financial $51.90 / +0.68 (+1.33%) 03/01/21 WSFS Financial to replace Cleveland-Cliffs in S&P 600 at open on 3/1 02/23/21 WSFS Financial to replace Cleveland-Cliffs in S&P 600 at open on 3/1 WSFS WSFS Financial $51.90 / +0.68 (+1.33%) 03/01/21 Piper Sandler WSFS Financial downgraded to Neutral from Overweight at Piper Sandler 02/25/21 Keefe Bruyette WSFS Financial downgraded to Market Perform from Outperform at Keefe Bruyette 04/01/20 Keefe Bruyette WSFS Financial upgraded to Outperform from Market Perform at Keefe Bruyette WSFS WSFS Financial $51.90 / +0.68 (+1.33%) 01/25/21 WSFS Financial reports Q4 EPS $1.20, consensus 91c 10/22/20 WSFS Financial reports Q3 EPS $1.01, consensus 72c WSFS WSFS Financial $51.90 / +0.68 (+1.33%) 01/25/21 Fly Intel: After-Hours Movers

Hot Stocks	Skylight Health to acquire three U.S. primary care practices » 07:41 03/04/21 03/04 07:41 03/04/21 07:41 SHGFF Skylight Health $0.00 / + (+0.00%) Skylight Health Group is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research SHGFF Skylight Health $0.00 / + (+0.00%) 02/26/21 Skylight Health appoints Andrew Elinesky as CFO 02/24/21 Skylight Health to host KOL event on U.S. healthcare market 02/17/21 Skylight Health appoints Jerry Oliphant as COO, Georges Feghali as CMO 02/09/21 Skylight Health appoints Paul Kulas as SVP, operations SHGFF Skylight Health $0.00 / + (+0.00%) 02/24/21 Raymond James Skylight Health initiated with an Outperform at Raymond James
Hot Stocks	Dyne Therapeutics expects cash to fund requirements into 2H24 » 07:40 03/04/21 03/04 07:40 03/04/21 07:40 DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) In January 2021, Dyne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) 07:30 Today Dyne Therapeutics appoints Wildon Farwell as CMO 02/08/21 Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs 01/10/21 Dyne Therapeutics announced new preclinical data from DM1 program 09/28/20 Citadel Advisors takes 6.5% passive stake in Dyne Therapeutics DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) 02/09/21 Dyne Therapeutics initiated with a Buy at JonesTrading 01/07/21 Piper Sandler Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper 10/12/20 Jefferies Dyne Therapeutics initiated with a Buy at Jefferies 10/12/20 JPMorgan Dyne Therapeutics initiated with an Overweight at JPMorgan DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) 07:39 Today Dyne Therapeutics reports Q4 EPS (64c), consensus (37c) 11/05/20 Dyne Therapeutics reports Q3 EPS ($2.01), consensus (87c) 21 Jan 17 Sep DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 09/28/20 Fly Intel: After-Hours Movers 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever
Earnings	Dyne Therapeutics reports Q4 EPS (64c), consensus (37c) » 07:39 03/04/21 03/04 07:39 03/04/21 07:39 DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) "2020 was a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) 07:30 Today Dyne Therapeutics appoints Wildon Farwell as CMO 02/08/21 Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs 01/10/21 Dyne Therapeutics announced new preclinical data from DM1 program 09/28/20 Citadel Advisors takes 6.5% passive stake in Dyne Therapeutics DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) 02/09/21 Dyne Therapeutics initiated with a Buy at JonesTrading 01/07/21 Piper Sandler Dyne Therapeutics potential beneficiary of Sarepta's SRP-9001 miss, says Piper 10/12/20 Jefferies Dyne Therapeutics initiated with a Buy at Jefferies 10/12/20 JPMorgan Dyne Therapeutics initiated with an Overweight at JPMorgan DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) 11/05/20 Dyne Therapeutics reports Q3 EPS ($2.01), consensus (87c) 21 Jan 17 Sep DYN Dyne Therapeutics $16.73 / -1.02 (-5.75%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 09/28/20 Fly Intel: After-Hours Movers 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever
Hot Stocks	Arbutus Biopharma sees cash runway into 3Q22 » 07:38 03/04/21 03/04 07:38 03/04/21 07:38 ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) Arbutus had cash, cash… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) 02/26/21 Assembly Biosciences, Arbutus initiate Phase 2 trial of combination therapy 01/25/21 Arbutus Biopharma sees cash runway into mid-2022 01/25/21 Arbutus Biopharma announces 2021 corporate objectives 12/10/20 Arbutus Biopharma announces additional HBsAg decline data with AB-729 ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) 12/17/20 H.C. Wainwright Arbutus Biopharma initiated with a Buy at H.C. Wainwright 09/15/20 Chardan Arbutus HBV data 'could represent a turning point,' says Chardan 07/27/20 B. Riley FBR Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR 07/24/20 Baird Arbutus Biopharma upside priced in, Baird downgrades to Neutral ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) 07:38 Today Arbutus Biopharma reports 2020 EPS ($1.00), consensus (98c) 11/05/20 Arbutus Biopharma reports Q3 EPS (27c), consensus (22c) 08:45 Today Arbutus Biopharma - ABUS ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) 12/15/20 Arbutus Biopharma call buyer realizes 80% same-day gains
Initiation	Histogen initiated with a Buy at Canaccord » 07:38 03/04/21 03/04 07:38 03/04/21 07:38 HSTO Histogen $1.15 / -0.035 (-2.95%) Canaccord Genuity analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Syndicate Options HSTO Histogen $1.15 / -0.035 (-2.95%) 02/16/21 Histogen announces Week 26 HST-001 study results 01/19/21 Histogen reports clinical hold on Phase 1/2 Trial of HST-003 for knee cartilage 12/17/20 Histogen files IND application for HST-003 12/01/20 Histogen announces preliminary week 18 HST-001 study results 31 Dec HSTO Histogen $1.15 / -0.035 (-2.95%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th

Earnings	Arbutus Biopharma reports 2020 EPS ($1.00), consensus (98c) » 07:38 03/04/21 03/04 07:38 03/04/21 07:38 ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) Reports 2020 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) 02/26/21 Assembly Biosciences, Arbutus initiate Phase 2 trial of combination therapy 01/25/21 Arbutus Biopharma sees cash runway into mid-2022 01/25/21 Arbutus Biopharma announces 2021 corporate objectives 12/10/20 Arbutus Biopharma announces additional HBsAg decline data with AB-729 ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) 12/17/20 H.C. Wainwright Arbutus Biopharma initiated with a Buy at H.C. Wainwright 09/15/20 Chardan Arbutus HBV data 'could represent a turning point,' says Chardan 07/27/20 B. Riley FBR Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR 07/24/20 Baird Arbutus Biopharma upside priced in, Baird downgrades to Neutral ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) 11/05/20 Arbutus Biopharma reports Q3 EPS (27c), consensus (22c) 08:45 Today Arbutus Biopharma - ABUS ABUS Arbutus Biopharma $3.64 / -0.19 (-4.97%) 12/15/20 Arbutus Biopharma call buyer realizes 80% same-day gains
Hot Stocks	Dicerna, Roche begin combo trial of GalXC for chronic HBV treatment » 07:37 03/04/21 03/04 07:37 03/04/21 07:37 DRNA Dicerna $29.00 / -0.52 (-1.76%) , RHHBY Roche $0.00 / + (+0.00%) Dicerna Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events DRNA RHHBY DRNA Dicerna $29.00 / -0.52 (-1.76%) 02/11/21 Dicerna initiates dosing in clinical trial of nedosiran for PH3 01/05/21 Dicerna announces first Novo Nordisk nominated candidate under agreement 01/04/21 Dicerna reports enrollment completion of PHYOX2 nedosiran trial 11/16/20 Dicerna gets $10M milestone from Lilly pact, Lilly initiates LY3561774 trial RHHBY Roche $0.00 / + (+0.00%) 03/03/21 Adaptive says Genentech suspends development of shared antigen target candidate 02/26/21 Regeneron announces CHMP recommendation for COVID-19 antibody cocktail 02/24/21 Prothena announces presentation of new preclinical PRX005 data 02/19/21 Atea Pharmaceuticals announces Chugai in-license of AT-527 from Roche DRNA RHHBY DRNA Dicerna $29.00 / -0.52 (-1.76%) 03/02/21 H.C. Wainwright Dicerna price target raised to $40 from $35 at H.C. Wainwright 03/02/21 Chardan Dicerna price target raised to $34 from $25 at Chardan 03/01/21 B. Riley Securities Dicerna price target raised to $40 from $37 at B. Riley Securities 01/11/21 B. Riley Securities Dicerna price target raised to $37 from $30 at B. Riley Securities RHHBY Roche $0.00 / + (+0.00%) 03/03/21 Goldman Sachs Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs 02/25/21 Berenberg Roche price target lowered to CHF 320 from CHF 325 at Berenberg 02/24/21 Morgan Stanley Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list DRNA RHHBY DRNA Dicerna $29.00 / -0.52 (-1.76%) 02/25/21 Dicerna reports FY20 EPS ($1.52), consensus ($1.05) 11/05/20 Dicerna reports Q3 EPS (29c), consensus (20c) RHHBY Roche $0.00 / + (+0.00%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year RHHBY RHHBY Roche $0.00 / + (+0.00%) 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports DRNA RHHBY DRNA Dicerna $29.00 / -0.52 (-1.76%) 02/25/21 Fly Intel: After-Hours Movers RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks 03/25/21 Roche - RHHBY
Upgrade	Agricultural Bank of China upgraded to Buy from Neutral at Goldman Sachs » 07:37 03/04/21 03/04 07:37 03/04/21 07:37 ACGBY Agricultural Bank of China $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ACGBY Agricultural Bank of China $0.00 / + (+0.00%) 04/03/20 Jefferies Agricultural Bank of China initiated with a Buy at Jefferies
Hot Stocks	Verrica Pharmaceuticals expects cash to support operations at least into 1Q22 » 07:36 03/04/21 03/04 07:36 03/04/21 07:36 VRCA Verrica Pharmaceuticals $15.18 / +0.97 (+6.83%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events VRCA Verrica Pharmaceuticals $15.18 / +0.97 (+6.83%) 07:35 Today Verrica says Torii exercises option to acquire license for VP-102 07:34 Today Verrica Pharmaceuticals resubmits NDA for VP-102 02/17/21 Verrica announces acceptance of resubmitted NDA filing for VP-102 01/19/21 Verrica Pharmaceuticals presents data from clinical studies of VP-102 VRCA Verrica Pharmaceuticals $15.18 / +0.97 (+6.83%) 12/24/20 Cowen Verrica approval for molluscum likely in Q3 of 2021, says Cowen 12/24/20 H.C. Wainwright Verrica Pharmaceuticals price target raised to $21 from $18 at H.C. Wainwright 07/15/20 BofA Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA 06/30/20 H.C. Wainwright Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright VRCA Verrica Pharmaceuticals $15.18 / +0.97 (+6.83%) 07:33 Today Verrica Pharmaceuticals reporrts Q4 EPS (52c), consensus (42c) 11/09/20 Verrica Pharmaceuticals reports Q3 EPS (42c), consensus (43c) 06/23/21 PDFUA Date for VP-102 Resubmission
Upgrade	Canaccord upgrades Okta to Buy on recent selloff, accretive acquisition » 07:36 03/04/21 03/04 07:36 03/04/21 07:36 OKTA Okta $242.42 / -16.595 (-6.41%) Canaccord analyst T.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options OKTA Okta $242.42 / -16.595 (-6.41%) 03/03/21 Okta drops 13% to $210.50 after Q1, FY22 profit view miss estimates 03/03/21 Okta to acquire Auth0 in deal valued at roughly $6.5B 12/02/20 Okta jumps 6.8% to $246 after Q3 results, FY21 guidance, AWS availability 12/02/20 Okta announces availability of Identity Cloud in AWS Marketplace OKTA Okta $242.42 / -16.595 (-6.41%) 06:53 Today Deutsche Bank Okta price target lowered to $270 from $313 at Deutsche Bank 06:45 Today Mizuho Okta price target lowered to $255 from $305 at Mizuho 06:37 Today Baird Okta price target lowered to $240 from $275 at Baird 06:06 Today Piper Sandler Okta price target lowered to $235 from $250 at Piper Sandler OKTA Okta $242.42 / -16.595 (-6.41%) 03/03/21 Okta sees FY22 adjusted EPS (49c)-(44c), consensus 1c 03/03/21 Okta sees Q1 adjusted EPS (21c)-(20c), consensus (7c) 03/03/21 Okta reports Q4 adjusted EPS 6c, consensus (1c) 03/03/21 Notable companies reporting after market close OKTA Okta $242.42 / -16.595 (-6.41%) 03/03/21 Fly Intel: After-Hours Movers 12/21/20 Analysts move to sidelines on SolarWinds following cyberattack 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 12/02/20 Fly Intel: After-Hours Movers OKTA Okta $242.42 / -16.595 (-6.41%) 12/02/20 Okta options imply 9.8% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

HCM
Today at 08:00

Hutchison China MediTech - HCM Conference Calls
BALY
Today at 08:00

Bally's - BALY Conference Calls
ATC
Today at 08:00

Atotech - ATC Conference Calls
WVE
Today at 08:00

Wave Life Sciences - WVE Conference Calls
FULC
Today at 08:00

Fulcrum Therapeutics - FULC Conference Calls
Today at 08:00

Consumer Data Analytics Industry Meetings
Today at 08:30

Initial Jobless Claims Change: Week 2/27/2021 Government Event
Today at 08:30

Jobless Claims: 4-Week Moving Average: Week 2/27/2021 Government Event
Today at 08:30

Productivity & Costs: Non-farm Poductivity Annual Rate: Q4(r):2020 Government Event
Today at 08:30

Productivity and Costs: Unit Labor Costs Annual Rate: Q4(r):2020 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan Priced at: $74.95 4.65M Shares
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50-47.00 3.9M Shares AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR $11.50-11.75 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

KBR price target raised to $40 from $34 at Truist

TODAY'S FREE FLY STORIES

Get Full Fly Access